Stock screenerAll disclosures →
EDGAR →
ELAN
Conviction 56HealthcareScan · Fri, Jun 26, 2026ELAN$24.56+0.78%
ResistanceSupportVol 14Insider buyCongress buyCongress sell2
Vol MA14 5.65M
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price24.56
Change+0.78%
Gap-0.27%
Rel volume1.54×
Avg volume5.94M
Avg $ vol142.39M
SMA 2023.97
SMA 5023.02
SMA 20022.76
Price vs 50+6.69%
Price vs 200+7.90%
MA stackbullish
50/200 cross—
Supertrendup · 21.95
RSI (14)56
MACD hist0.01
MACD crossbull · 0d
Stoch %K / %D75 / 60
ADX (14)12
+DI / −DI27 / 22
RSI divergence—
MACD divergence—
ATR %+4.23%
ADR %4.16%
52w high26.84
52w low13.68
From 52w high-8.49%
Above 52w low+79.53%
New 52w highNo
SqueezeOn · 5d
Bollinger width7.98%
%B0.81
Donchian pos51.87%
Donchian high26.23
Donchian low22.76
AVWAP (52w high)23.52
vs AVWAP high+4.40%
AVWAP (52w low)21.73
vs AVWAP low+13.01%
OBV trendFlat
Chaikin MF (20)-0.10
Today vs 20d1.54×
Avg vol (14d)5.65M
Avg vol (20d)5.94M
Avg $ vol (20d)142.39M
Market cap—
RS 3m (vs SPY)-16.23%
RS 6m (vs SPY)+2.06%
RS line new highNo
Trend template6/8
Technical rank70.8
1 week+1.40%
1 month+3.67%
3 months-0.08%
6 months+10.53%
1 year+78.49%
YTD+9.06%
P/E-52.43
P/B1.87
P/S2.58
P/FCF42.83
EPS-0.4700
Div yield—
ROE-3.57%
ROA-1.75%
Debt/Eq0.68
Current2.16
EV/EBITDA—
Gross margin54.99%
Net margin-4.92%
Rev growth6.22%
EPS growth-168.64%
Price target29.67
Target upside21.82%
Analyst ratingBuy
Institutional119.21%
Ent. value16.13B
Revenue1.37B
Net income57M
Gross profit785M
Free cash flow284M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out499.45M
Employees9.9K
ListedThu, Sep 20, 2018
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction56 / 100
Pattern quality—
Tech rank70.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance26.26
Support20.29
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ELAN · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 |
Insider activity
SEC Form 4 transactions in ELAN · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
VanHimbergen Robert M EVP and CFO · Deferred Stock Units · 2026-05-29 | Grant | 8.261 | $197 | 2026-05-29 | 2026-06-02 |
Modi Rajeev A. SEE REMARKS · Deferred Stock Units · 2026-05-29 | Grant | 61.926 | $1K | 2026-05-29 | 2026-06-02 |
Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR · Deferred Stock Units · 2026-05-29 | Grant | 118.53 | $3K | 2026-05-29 | 2026-06-02 |
Herendeen Paul Director · Common Stock · 2026-05-21 | Grant | 12.2K | $0 | 2026-05-21 | 2026-05-26 |
Harrington Michael J Director · Common Stock · 2026-05-21 | Grant | 4.68K | $0 | 2026-05-21 | 2026-05-26 |
Herendeen Paul Director · Common Stock · 2026-05-21 | Grant | 4.68K | $0 | 2026-05-21 | 2026-05-26 |
GARCIA ART A Director · Common Stock · 2026-05-21 | Grant | 12.2K | $0 | 2026-05-21 | 2026-05-26 |
Scots-Knight Denise Director · Common Stock · 2026-05-21 | Grant | 12.2K | $0 | 2026-05-21 | 2026-05-26 |
Ma Stacey Director · Common Stock · 2026-05-21 | Grant | 12.2K | $0 | 2026-05-21 | 2026-05-26 |
HOOVER R DAVID Director · Common Stock · 2026-05-21 | Grant | 4.68K | $0 | 2026-05-21 | 2026-05-26 |
SEC filings
EDGAR filings in ELAN
No recent SEC filings on file for ELAN.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.